Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.

Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.

Item
http://www.wikidata.org/entity/Q41487407
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis.Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?Deletion of Macrophage Mineralocorticoid Receptor Protects Hepatic Steatosis and Insulin Resistance Through ERα/HGF/Met Pathway.Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.The selective mineralcorticoid receptor (MR) antagonist eplerenon prevents decompensation of liver cirrhosis.Fatty Liver Disease, Women, and Aldosterone: Finding a Link in the Jackson Heart Study.
P2860

Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.

Item
http://www.wikidata.org/entity/Q41487407
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Beneficial effects of mineralo ...... non-alcoholic steatohepatitis.
@en
type
label
Beneficial effects of mineralo ...... non-alcoholic steatohepatitis.
@en
prefLabel
Beneficial effects of mineralo ...... non-alcoholic steatohepatitis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Beneficial effects of mineralo ...... non-alcoholic steatohepatitis
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932